Gamma-butyrolactone

Gamma-butyrolactone is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 14993 references associated with Gamma-butyrolactone in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Gamma-butyrolactone

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gamma-butyrolactone

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Ataxia D001259 20 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Stomach Ulcer D013276 75 associated lipids
Weight Loss D015431 56 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Total 9

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Gamma-butyrolactone

Download all related citations
Per page 10 20 50 100 | Total 3467
Authors Title Published Journal PubMed Link
pmid:6683846
Watanabe K et al. gamma-butyrolactone enhances the activity of GABA in the gastric acid secretion of anesthetized rats. 1983 Jpn. J. Pharmacol. pmid:6668764
pmid:6541070
Pericić D et al. Post-mortem and aminooxyacetic acid-induced accumulation of GABA: effect of gamma-butyrolactone and picrotoxin. 1978 J. Neurochem. pmid:650217
Weissman BA et al. Alkyl-substituted gamma-butyrolactones inhibit [35S]TBPS binding to a GABA linked chloride ionophore. 1984 Eur. J. Pharmacol. pmid:6489449
Truscott RJ et al. New metabolites in isovaleric acidemia. 1981 Clin. Chim. Acta pmid:6452974
Gräfe U et al. Modification by genetic changes of the pleiotropic interference of butyrolactone-type autoregulators with differentiation of Streptomyces griseus. 1984 Z. Allg. Mikrobiol. pmid:6438925
Hidaka T et al. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase. 1984 Jpn. J. Pharmacol. pmid:6438380
pmid:6434327
Gräfe U et al. Pleiotropic effects of a butyrolactone-type autoregulator on mutants of Streptomyces griseus blocked in cytodifferentiation. 1984 J. Gen. Microbiol. pmid:6432945
pmid:6432559
Horinouchi S et al. Unstable genetic determinant of A-factor biosynthesis in streptomycin-producing organisms: cloning and characterization. 1984 J. Bacteriol. pmid:6427181
pmid:6423212
Gräfe U and Eritt I On the biological inactivity of 4,5-dihydroxy-n-decanoic acid-4-lactones. 1983 J. Antibiot. pmid:6418706
Gräfe U et al. Effect of the autoregulator from Streptomyces griseus JA 5142 on surface cultures of blocked mutant ZIMET 43682. 1983 Z. Allg. Mikrobiol. pmid:6415935
Hara O et al. Genetic analysis of A-factor synthesis in Streptomyces coelicolor A3(2) and Streptomyces griseus. 1983 J. Gen. Microbiol. pmid:6415235
pmid:6413231
pmid:6406238
pmid:6403019
pmid:6378032